Hosted on MSN11mon
Search for Cancer Blood Test Continues Despite Illumina-Grail Deal’s Failure
Investors shelved their hopes for a pioneering cancer blood test after Illumina‘s $8 billion acquisition ... small real-world study to validate its panel of DNA and protein biomarkers.
pharmaphorum25d
IBM Watson, Illumina collaborate on cancer genetics decision-making
IBM Watson Health's Watson for Genomics platform is to help inform cancer treatment ... to data from Illumina's TruSight Tumor 170 platform - a next generation sequencing gene panel that provides ...
The Scientist6mon
FDA approves Illumina cancer biomarker test with two companion diagnostics to rapidly match patients to targeted therapies
chief commercial officer of Illumina. “We are committed to partnering with industry leaders like Bayer and Lilly to advance cancer diagnostics and help broaden access to precision oncology for more ...
Nature2y
Innovation at Illumina: The road to the $600 human genome
Illumina is an applied genomics technology company ... in a patient’s genome for possible predisposition to cancers. Cancer is a disease in the genome, but where do you start when it is peppered ...
The Financial Express on MSN6mon
Illumina announces global expansion plans in India; To establish Global Capability Center in Bengaluru
Illumina Inc., a key player in DNA sequencing ... and one in nine people in India are likely to develop cancer in their ...